North America Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Others), By Test Location, By Technology (PCR, ISH, INAAT, Sequencing), By Application, By Country, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-1-68038-073-6
- Number of Pages: 120
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- North America Molecular Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
- Instruments
- Reagents
- Others
- North America Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
- Point-of-Care
- Self-test or Over the Counter
- Central Laboratories
- North America Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
- Polymerase Chain Reaction (PCR)
- PCR, by Type
- Multiplex PCR
- Other PCR
- PCR, by Procedure
- Nucleic Acid Extraction
- Others
- PCR, by Product
- Instruments
- Reagents
- Others
- PCR, by Type
- In Situ Hybridization
- Instruments
- Reagents
- Others
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Instruments
- Reagents
- Others
- Chips and Microarrays
- Instruments
- Reagents
- Others
- Mass spectroscopy
- Instruments
- Reagents
- Others
- Sequencing
- Instruments
- Reagents
- Others
- Transcription Mediated Amplification (TMA)
- Instruments
- Reagents
- Others
- Others
- Instruments
- Reagents
- Others
- Polymerase Chain Reaction (PCR)
- North America Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
- Oncology
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Kidney Cancer
- Liver Cancer
- Blood Cancer
- Lung Cancer
- Other Cancer
- Pharmacogenomics
- Infectious Diseases
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Clostridium Difficile
- Vancomycin-resistant Enterococci (VRE)
- Carbapenem-resistant Bacteria
- Flu
- Respiratory Syncytial Virus (RSV)
- Candida
- Tuberculosis and Drug-resistant TBA
- Meningitis
- Gastrointestinal Panel Testing
- Chlamydia
- Gonorrhea
- HIV
- Hepatitis C
- Hepatitis B
- Other Infectious Disease
- Genetic Testing
- Newborn Screening
- Predictive and Presymptomatic Testing
- Other Genetic Testing
- Neurological Disease
- Cardiovascular Disease
- Microbiology
- Others
- Oncology
- North America Molecular Diagnostics Market Regional Outlook (USD Million, 2018 - 2030)
- U.S.
- U.S. Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
- Instruments
- Reagents
- Others
- U.S. Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
- Point-of-Care
- Self-test or Over the Counter
- Central Laboratories
- U.S. Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
- Polymerase Chain Reaction (PCR)
- PCR, by Type
- Multiplex PCR
- Other PCR
- PCR, by Procedure
- Nucleic Acid Extraction
- Others
- PCR, by Product
- Instruments
- Reagents
- Others
- PCR, by Type
- In Situ Hybridization
- Instruments
- Reagents
- Others
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Instruments
- Reagents
- Others
- Chips and Microarrays
- Instruments
- Reagents
- Others
- Mass spectroscopy
- Instruments
- Reagents
- Others
- Sequencing
- Instruments
- Reagents
- Others
- Transcription Mediated Amplification (TMA)
- Instruments
- Reagents
- Others
- Others
- Instruments
- Reagents
- Others
- Polymerase Chain Reaction (PCR)
- U.S. Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
- Oncology
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Kidney Cancer
- Liver Cancer
- Blood Cancer
- Lung Cancer
- Other Cancer
- Pharmacogenomics
- Infectious Diseases
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Clostridium Difficile
- Vancomycin-resistant Enterococci (VRE)
- Carbapenem-resistant Bacteria
- Flu
- Respiratory Syncytial Virus (RSV)
- Candida
- Tuberculosis and Drug-resistant TBA
- Meningitis
- Gastrointestinal Panel Testing
- Chlamydia
- Gonorrhea
- HIV
- Hepatitis C
- Hepatitis B
- Other Infectious Disease
- Genetic Testing
- Newborn Screening
- Predictive and Presymptomatic Testing
- Other Genetic Testing
- Neurological Disease
- Cardiovascular Disease
- Microbiology
- Others
- Oncology
- U.S. Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
- Canada
- Canada Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
- Instruments
- Reagents
- Others
- Canada Molecular Diagnostics Market Test Location Outlook (USD Million, 2018 - 2030)
- Point-of-Care
- Self-test or Over the Counter
- Central Laboratories
- Canada Molecular Diagnostics Market Technology Outlook (USD Million, 2018 - 2030)
- Polymerase Chain Reaction (PCR)
- PCR, by Type
- Multiplex PCR
- Other PCR
- PCR, by Procedure
- Nucleic Acid Extraction
- Others
- PCR, by Product
- Instruments
- Reagents
- Others
- PCR, by Type
- In Situ Hybridization
- Instruments
- Reagents
- Others
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Instruments
- Reagents
- Others
- Chips and Microarrays
- Instruments
- Reagents
- Others
- Mass spectroscopy
- Instruments
- Reagents
- Others
- Sequencing
- Instruments
- Reagents
- Others
- Transcription Mediated Amplification (TMA)
- Instruments
- Reagents
- Others
- Others
- Instruments
- Reagents
- Others
- Polymerase Chain Reaction (PCR)
- Canada Molecular Diagnostics Market Application Outlook (USD Million, 2018 - 2030)
- Oncology
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Kidney Cancer
- Liver Cancer
- Blood Cancer
- Lung Cancer
- Other Cancer
- Pharmacogenomics
- Infectious Diseases
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Clostridium Difficile
- Vancomycin-resistant Enterococci (VRE)
- Carbapenem-resistant Bacteria
- Flu
- Respiratory Syncytial Virus (RSV)
- Candida
- Tuberculosis and Drug-resistant TBA
- Meningitis
- Gastrointestinal Panel Testing
- Chlamydia
- Gonorrhea
- HIV
- Hepatitis C
- Hepatitis B
- Other Infectious Disease
- Genetic Testing
- Newborn Screening
- Predictive and Presymptomatic Testing
- Other Genetic Testing
- Neurological Disease
- Cardiovascular Disease
- Microbiology
- Others
- Oncology
- Canada Diagnostics Market Product Outlook (USD Million, 2018 - 2030)
- U.S.
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
